Concepedia

Leslie Wetzel

LW

Statistics

Publications

9

Citations

998

H-Index

9

Active since

2015

Affiliations

Altimmune (United States)(Current)

AstraZeneca (United Kingdom)

Spirogen (United Kingdom)

Leslie Wetzel is an author at Altimmune (United States) specializing in cancer immunotherapy, oncology, and pharmacology.

Publications per year

2015–2022

9

Publications

9

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

John Y. Li, Samuel R. Perry, Vanessa Muniz‐Medina et al. · Cancer Cell · 2016 · 390 citations · Full text

, , +14

Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models

Jonathan Rios‐Doria, Nicholas M. Durham, Leslie Wetzel et al. · Neoplasia · 2015 · 172 citations · Full text

, , +17

Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies

Jonathan Rios‐Doria, Jay Harper, Raymond Rothstein et al. · Cancer Research · 2017 · 134 citations

, , +17

Anti–PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC

Eric Tu, Kelly McGlinchey, Jixin Wang et al. · JCI Insight · 2022 · 109 citations · Full text

, , +17

Preclinical assessment of an antibody–PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cells

Krista Kinneer, Matt Flynn, Suneetha B. Thomas et al. · Leukemia · 2018 · 61 citations

, , +17

1–5 of 9